Don't miss the chance for call for Late-breaking Abstracts submission!
Many clinical trials, including industry-initiated and investigator-initiated clinical trials, are being conducted in Japan and abroad. In some of these clinical trials, test results become available after the closure of submission, while the results of others may be presented at international scientific meetings held immediately before the 109th Annual Meeting. Many urologists are surely keen to hear of such results.
We therefore have decided to have a Late-breaking Session during the 109th Annual Meeting to immediately share the latest findings with the association’s members.
We invite those wishing to share their latest research results at this session to submit abstracts.
Late-breaking Abstracts Submission has been Closed.
The first author of the presentation must disclose all necessary information in the provided COI form at the time of abstract submission.
1 | Adrenals | 12 | Neuro-urology |
---|---|---|---|
2 | Upper tract benign disease | 13 | Incontinence |
3 | Kidney transplantation | 14 | Infertility |
4 | Renal tumors | 15 | Andrology |
5 | Urothelial tumors | 16 | Sexual dysfunction |
6 | Urinary reconstruction | 17 | Infectious disease |
7 | Prostate cancer | 18 | Stones |
8 | Testis tumors | 19 | Trauma and emergencies |
9 | Penile cancer | 20 | Pediatric urology |
10 | Male LUTS | 21 | Urethroplasty and genital reconstruction |
11 | Female LUTS | 22 | Others |
Abstracts must be submitted in English, not exceeding 1600 characters.
The material for presentation should be unpublished and original.
Should you need further information, please contact us.
c/o Congrès Inc.
E-mail: jua2021-abs@congre.co.jp